Become a Member

EAACI Congress 2025 Back

13 - 16 June 2025 Glasgow, United Kingdom

Marc Riedl

United States of America

Marc Riedl

Sessions

Friday 13 Jun
17:09 - 17:21 Improvements in Quality of Life in Patients With Hereditary Angioedema Receiving Donidalorsen: Post Hoc Analysis From the OASIS-HAE Study and Results From the OASISplus Open-Label Extension
Saturday 14 Jun
12:00 - 13:00
SAT14 CSL Behring - Changing the Flow: Shifting Hereditary Angioedema Treatment Toward Normalization of Patients’ Lives Sponsored Sessions Meeting Academy M1
12:45 - 13:00 Q&A - Interactivity
Long-Term Analysis of the Phase 2 Open-Label Extension of Donidalorsen in Patients With Hereditary Angioedema
The impact of treatment switching on healthcare resource utilization among patients with hereditary angioedema in the United States
×